Japan has approved the Novavax vaccine for COVID-19

Japan’s health ministry committee said it approved Novavax’s COVID-19 vaccine, paving the way for full approval of the country’s fourth coronavirus vaccine. The Japanese government has agreed to purchase 150 million doses of Novavax, a recombinant protein vaccine.

Share this post:

Related Posts
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
WordPress Cookie Plugin by Real Cookie Banner